Detalles de la búsqueda
1.
The effect of chemotherapy on the exposure-response relation of abiraterone in metastatic castration-resistant prostate cancer.
Br J Clin Pharmacol
; 88(3): 1170-1178, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34436788
2.
Prognostic Value of Novel Liquid Biomarkers in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: A Prospective Observational Study.
Clin Chem
; 66(6): 842-851, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32408351
3.
In depth: The drug interaction between trimethoprim-sulfamethoxazole and folic acid/folinic acid.
Br J Clin Pharmacol
; 2024 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38880972
4.
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment: an update.
Lancet Oncol
; 24(6): e229, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37269847
5.
A Prospective Randomised Trial to Determine the Effect of a Reduced Versus Standard Dose of Enzalutamide on Side Effects in Frail Patients with Prostate Cancer.
Eur Urol Oncol
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485614
6.
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Nat Commun
; 15(1): 1828, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418825
7.
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-Darolutamide.
Clin Pharmacokinet
; 62(8): 1049-1061, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37458966
8.
Prognostic Value of Nivolumab Clearance in Non-Small Cell Lung Cancer Patients for Survival Early in Treatment.
Clin Pharmacokinet
; 62(12): 1749-1754, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37856040
9.
Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.
Clin Cancer Res
; 29(15): 2835-2844, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36996325
10.
Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs.
Lancet Haematol
; 9(1): e58-e72, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890539
11.
Deep and ongoing response of castrate-resistant prostate cancer on very low-dose enzalutamide in an elderly chemotherapy-naïve patient: a case report.
Cancer Chemother Pharmacol
; 88(1): 165-168, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33817752
12.
Liquid biopsy reveals KLK3 mRNA as a prognostic marker for progression free survival in patients with metastatic castration-resistant prostate cancer undergoing first-line abiraterone acetate and prednisone treatment.
Mol Oncol
; 15(9): 2453-2465, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33650292
13.
RNA Biomarkers as a Response Measure for Survival in Patients with Metastatic Castration-Resistant Prostate Cancer.
Cancers (Basel)
; 13(24)2021 Dec 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34944897
14.
Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Expert Rev Mol Diagn
; 20(2): 219-230, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31577907
15.
A Systematic Review and Meta-Analysis on the Predictive Value of Cell-Free DNA-Based Androgen Receptor Copy Number Gain in Patients With Castration-Resistant Prostate Cancer.
JCO Precis Oncol
; 4: 714-729, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35050750
16.
[Drug-facilitated sexual assault; frequently used substances, symptoms and toxicological investigation]. / Verkrachting onder invloed.
Ned Tijdschr Geneeskd
; 1632019 01 31.
Artículo
en Neerlandesa
| MEDLINE | ID: mdl-30730679
Resultados
1 -
16
de 16
1
Próxima >
>>